Psyence Biomedical Ltd Stock Today
| PBMWW Stock | 0.01 0.0006 7.50% |
Performance8 of 100
| Odds Of DistressLess than 7
|
Psyence Biomedical is selling for under 0.0074 as of the 27th of November 2024; that is 7.5 percent down since the beginning of the trading day. The stock's lowest day price was 0.0062. Psyence Biomedical has only a 7 % chance of going through financial distress over the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Psyence Biomedical Ltd are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
IPO Date 26th of January 2024 | Category Healthcare |
Psyence Biomedical is entity of United States. It is traded as Stock on NASDAQ exchange. More on Psyence Biomedical Ltd
Moving against Psyence Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Psyence Stock Highlights
| CEO Director | Neil MD | |||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
| Psyence Biomedical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Psyence Biomedical's financial leverage. It provides some insight into what part of Psyence Biomedical's total assets is financed by creditors. | ||||||||||||||||||||||||||||||||||||
Psyence Biomedical Ltd (PBMWW) is traded on NASDAQ Exchange in USA. It is located in 121 Richmond Street West, Toronto, ON, Canada, M5H2K1 and employs 6 people. Psyence Biomedical is listed under Pharmaceutical Products category by Fama And French industry classification. The company classifies itself under Healthcare sector and is part of Biotechnology industry.
Check Psyence Biomedical Probability Of Bankruptcy
Psyence Biomedical Historical Income Statement
Psyence Stock Against Markets
Psyence Biomedical Corporate Management
| Taryn Vos | General Counsel | Profile | |
| Tony Budden | Chief Officer | Profile | |
| MaryElizabeth Gifford | Executive Impact | Profile | |
| Warwick CordenLloyd | Chief Officer | Profile |
Additional Tools for Psyence Stock Analysis
When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.